Home » Topics » BioWorld Science

BioWorld Science
RSS

The Wellcome Foundation claims nitric oxide synthase inhibitors

Aug. 23, 1996

Nitric oxide synthase inhibitors from Merck & Co.

Aug. 23, 1996

BASF reveals NMDA and AMPA antagonists

Aug. 23, 1996

UPF-596 described as a novel glutamate antagonist

Aug. 23, 1996

Nymox Pharmaceuticals present positive results from AD7C trial

Aug. 23, 1996

Study of senile plaques guide Alzheimer's development

Aug. 23, 1996

Study indicates that estrogen may delay Alzheimer's disease onset

Aug. 23, 1996

Biogen signs Avonex distribution agreements

Aug. 23, 1996

Positive study results reported for CytoTherapeutics' encapsulated hCNTF device

Aug. 23, 1996

Zila to acquire Bio-Dental Technologies

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...